Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia
This study has been terminated.
Sponsor:
medac GmbH
Information provided by (Responsible Party):
medac GmbH
ClinicalTrials.gov Identifier:
NCT01251809
First received: November 26, 2010
Last updated: May 17, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | May 2013 |
| Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |